$6.080
-0.304 (-5.00%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
GYRE 相似圖表分析預測
Alphio's GYRE stock price prediction model matches the current Gyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.08 (-0.02%). The 1-week path is $5.72 (-5.99%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Gyre Therapeutics Inc 股票嗎?
Gyre Therapeutics is not a good buy right now due to significant financial challenges and poor technical indicators. The current price is $6.08, and the RSI is at a very low 18.42, indicating oversold conditions. Additionally, the stock has seen a 13.64% decline over the last five days and a staggering 27.10% drop over the past year, reflecting ongoing struggles. The main risk is the company's widening net loss, which reached $11.66 million in Q2 2026, a 472% increase from the previous year, raising concerns about its profitability and sustainability.
GYRE 股價於 Friday 收在 $6.08,此前下跌 -5.00%
Gyre Therapeutics Inc (GYRE) last closed at $6.08, losing -5.00%. These facts feed the 1-day and 1-week GYRE price prediction above.
預測驅動因素
Gyre Therapeutics Inc(GYRE)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 GYRE 最接近的股票,依相似度排序。
GYRE 季節性分析
Historically the probability of a positive October return for GYRE is 12.07%. February offers the highest probability of a positive month at 46.55%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。